Javascript must be enabled to continue!
METFORMIN-SENSITIVE ION-SELECTIVE ELECTRODE
View through CrossRef
Metformin in its protonated form as metformin hydrochloride is used worldwide as an advanced antidiabetic drug for type 2 diabetes. Hyperinsulinemia and insulin resistance of cells are the main causes of this disease. For patients with diabetes, metformin hydrochloride (MET) works by improving cell sensitivity to insulin.
It has been shown that metformin with methyl orange (MO) forms an ionic associate that can be isolated in solid form and is suitable for the creation of plasticized membrane potentiometric metformin-sensitive sensors.
The energy efficiency of IA formation is substantiated by the method of mathematical modeling. Molecular modeling of MO- + MET+ systems and related calculations were performed using the PM3 method for various initial variants of counter ion relative to each other (single point procedure). Geometric optimization of ions was performed by the method of molecular mechanics MM+. The standard enthalpy (ΔH0) of ion formation and the association “MET+ + MO-” was determined by the semi-empirical method PM3. The difference in the energy of formation of the ionic associate and the sum of the energies of formation of its components is 258 kJ/mol. Therefore, the process of IA formation is thermodynamically advantageous.
Modeling and optimization of membrane composition is carried out. The results of the study of the influence of the nature of plasticizers on the electroanalytical properties of the developed sensors indicate that the best plasticizer for the system is TCP or DNF. For these solvents, the product of the dielectric constant and Rohrschneider polarity (ε × PR) is 123.5 and 175, respectively. For plasticizers that were less effective (DBF and DEF), these values are 235.6 and 326 respectively. For membranes with the same content of plasticizer of one homologous series (DEF, DBF, DOF, DNF), the slope of the Nernst function decreases with increasing dielectric constant of the plasticizer solvent. It is shown that the working pH range of the electrode is from 2 to 11. The drift potential does not exceed 1-3 mV/day. Stable values of electrode potentials are set for 5-15 s. The stability of the electroanalytical characteristics of the optimized membranes can be traced for at least three months. The developed sensors show satisfactory selectivity in relation to a number of substances and ions. The 300-1000 amount of glucose, starch, polyvinyl alcohol, Na+, K+, Mg2+, Ca2+, Ba2+ ions do not interfere with MET determination. This, in turn, allows the practical use of developed MET-sensitive sensors in a variety of objects.
A method of potentiometric determination of metformin has been developed, which has been tested in its determination in dosage forms.
Title: METFORMIN-SENSITIVE ION-SELECTIVE ELECTRODE
Description:
Metformin in its protonated form as metformin hydrochloride is used worldwide as an advanced antidiabetic drug for type 2 diabetes.
Hyperinsulinemia and insulin resistance of cells are the main causes of this disease.
For patients with diabetes, metformin hydrochloride (MET) works by improving cell sensitivity to insulin.
It has been shown that metformin with methyl orange (MO) forms an ionic associate that can be isolated in solid form and is suitable for the creation of plasticized membrane potentiometric metformin-sensitive sensors.
The energy efficiency of IA formation is substantiated by the method of mathematical modeling.
Molecular modeling of MO- + MET+ systems and related calculations were performed using the PM3 method for various initial variants of counter ion relative to each other (single point procedure).
Geometric optimization of ions was performed by the method of molecular mechanics MM+.
The standard enthalpy (ΔH0) of ion formation and the association “MET+ + MO-” was determined by the semi-empirical method PM3.
The difference in the energy of formation of the ionic associate and the sum of the energies of formation of its components is 258 kJ/mol.
Therefore, the process of IA formation is thermodynamically advantageous.
Modeling and optimization of membrane composition is carried out.
The results of the study of the influence of the nature of plasticizers on the electroanalytical properties of the developed sensors indicate that the best plasticizer for the system is TCP or DNF.
For these solvents, the product of the dielectric constant and Rohrschneider polarity (ε × PR) is 123.
5 and 175, respectively.
For plasticizers that were less effective (DBF and DEF), these values are 235.
6 and 326 respectively.
For membranes with the same content of plasticizer of one homologous series (DEF, DBF, DOF, DNF), the slope of the Nernst function decreases with increasing dielectric constant of the plasticizer solvent.
It is shown that the working pH range of the electrode is from 2 to 11.
The drift potential does not exceed 1-3 mV/day.
Stable values of electrode potentials are set for 5-15 s.
The stability of the electroanalytical characteristics of the optimized membranes can be traced for at least three months.
The developed sensors show satisfactory selectivity in relation to a number of substances and ions.
The 300-1000 amount of glucose, starch, polyvinyl alcohol, Na+, K+, Mg2+, Ca2+, Ba2+ ions do not interfere with MET determination.
This, in turn, allows the practical use of developed MET-sensitive sensors in a variety of objects.
A method of potentiometric determination of metformin has been developed, which has been tested in its determination in dosage forms.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract
Background: Metformin, an oral biguanide used for the treatment of type-2 diabetes mellitus (DM), has been shown in a considerable number of studies to have...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Trace Mercury Ion Detection Sensor Employing SnO2/Rgo Nanocomposites Modified Electrode
Trace Mercury Ion Detection Sensor Employing SnO2/Rgo Nanocomposites Modified Electrode
Introduction
Heavy metal pollution seriously affects human health. Mercury is one of the most hazardous pollution, it has been accum...
Metformin and Exercise in Type 2 Diabetes
Metformin and Exercise in Type 2 Diabetes
OBJECTIVE
To determine the effect of metformin on the acute metabolic response to submaximal exercise, the effect of exercise on plasma metformin concentrations, ...
Metformin Inhibits Na+/H+ Exchanger NHE3 Resulting in Intestinal Water Loss
Metformin Inhibits Na+/H+ Exchanger NHE3 Resulting in Intestinal Water Loss
Glycemic control is the key to the management of type 2 diabetes. Metformin is an effective, widely used drug for controlling plasma glucose levels in diabetes, but it is often the...
Abstract 1682: Metformin synergistically enhances antitumor efficacy of sorafenib in vitro
Abstract 1682: Metformin synergistically enhances antitumor efficacy of sorafenib in vitro
Abstract
Background: Previously, we observed anti-tumor effect of sorafenib in osteosarcoma cells. However, a number of studies suggested that cancer cells might esc...
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
<p dir="ltr">Objectives: This study aimed to evaluate lactic acidosis (LA) risk when using metformin combined with histamine H2 receptor inhibitors (H2RI) in patients with re...

